Relapsed Or Refractory Pediatric Malignant Solid Tumors Including Neuroblastoma Rhabdomyosarcoma Ewing Sarcoma Osteosarcoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Relapsed Or Refractory Pediatric Malignant Solid Tumors Including Neuroblastoma Rhabdomyosarcoma Ewing Sarcoma Osteosarcoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

Not Yet RecruitingPhase 2

NCT07444918

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

This is a prospective, single-center, single-arm interventional trial conducted at Tianjin Medical University Cancer Institute and Hospital. It evaluates the ef…

Location not specified33 participantsStarted 2026-03-01

Treatment: Liposomal Irinotecan, Vincristine, Temozolomide, and Optional Anlotinib

CompletedPhase 1

NCT00303940

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors…

RATIONALE: Talabostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomid…

United States26 participantsStarted 2005-12

Treatment: carboplatin, talabostat mesylate